256 related articles for article (PubMed ID: 20000577)
1. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
3. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
[TBL] [Abstract][Full Text] [Related]
5. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
Huang Q; Mao J; Wan B; Wang Y; Brun R; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Nov; 52(21):6757-67. PubMed ID: 19817445
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
Mao J; Yuan H; Wang Y; Wan B; Pieroni M; Huang Q; van Breemen RB; Kozikowski AP; Franzblau SG
J Med Chem; 2009 Nov; 52(22):6966-78. PubMed ID: 19863050
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
9. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
Mao J; Yuan H; Wang Y; Wan B; Pak D; He R; Franzblau SG
Bioorg Med Chem Lett; 2010 Feb; 20(3):1263-8. PubMed ID: 20022500
[TBL] [Abstract][Full Text] [Related]
11. Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.
Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Apr; 21(7):2125-8. PubMed ID: 21320779
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents.
Mao J; Wang Y; Wan B; Kozikowski AP; Franzblau SG
ChemMedChem; 2007 Nov; 2(11):1624-30. PubMed ID: 17680579
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.
Lu X; Wan B; Franzblau SG; You Q
Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695
[TBL] [Abstract][Full Text] [Related]
14. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH
Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
De P; Koumba Yoya G; Constant P; Bedos-Belval F; Duran H; Saffon N; Daffé M; Baltas M
J Med Chem; 2011 Mar; 54(5):1449-61. PubMed ID: 21309577
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
18. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
20. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]